Form EFFECT Altamira Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 12, 2024 |
| Accession Number: | 0001213900-24-059862 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- StopOverpaying.org Surpasses 2 Million Users, Marking Major Milestone for Car Insurance Comparison Platform
- ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027
- AUX Officially Becomes Global Partner of Manchester City
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
